Prior to his current role as Deputy CIO, Josh ran the Life Sciences & Technology Lending group at MidCap Financial, overseeing the successful deployment of $3.5+ billion of debt investments to emerging life science and technology companies. Josh was previously head of underwriting for life science transactions at Merrill Lynch Capital Healthcare Finance and served as an Engagement Manager in the life sciences consulting practice at Leerink Swann, where he advised biotech, pharmaceutical, and device manufacturers on product strategy, business development, and M&A due diligence. Josh holds a PhD in human genetics and molecular biology from The Johns Hopkins School of Medicine, where he published 11 research articles in leading scientific and medical journals. He also holds a BS from the State University of New York/Syracuse University and an MS in biology from Vanderbilt University.